Evelyn Partners Investment Management Services’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.4K Hold
304
﹤0.01% 239
2025
Q4
$8.96K Hold
304
﹤0.01% 237
2025
Q3
$7.85K Hold
304
﹤0.01% 241
2025
Q2
$8.39K Hold
304
﹤0.01% 228
2025
Q1
$8.62K Hold
304
﹤0.01% 227
2024
Q4
$12.6K Buy
+304
New +$14.5K ﹤0.01% 223

Other funds holding MRNA

Evelyn Partners Investment Management Services's MRNA Position: Q1 2026 in Review

Evelyn Partners Investment Management Services held its Moderna (MRNA) position steady in Q1 2026 at 304 shares worth $15.4K. The position accounts for ﹤0.01% of the portfolio, ranked #239.

Evelyn Partners Investment Management Services first reported a position in MRNA in Q4 2024 and has held it in 6 quarters since. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Evelyn Partners Investment Management Services held 304 shares of Moderna worth $15.4K as of Q1 2026.
  • Evelyn Partners Investment Management Services left its Moderna share count unchanged in Q1 2026.
  • Moderna made up ﹤0.01% of Evelyn Partners Investment Management Services's portfolio in Q1 2026, its #239 holding.
  • Evelyn Partners Investment Management Services first reported a position in Moderna in Q4 2024 and has held it in 6 quarters since.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Evelyn Partners Investment Management Services's 13F filing for Q1 2026, filed 15 May 2026.